Indoco Remedies · NSE: INDOCO · BSE: 532612
Q2 FY19 results · Jul–Sep 2018
Indoco Remedies reported revenue from operations of ₹235.63 crore and net loss of ₹7.79 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 235.63 | — | — | 212.49 | +10.9% |
| Other income | 0.33 | — | — | 5.35 | −93.8% |
| Total income | 235.96 | — | — | 217.84 | +8.3% |
| Profit before tax | (10.52) | — | — | (12.02) | Loss narrowed |
| Net profit for the period | (7.79) | — | — | (12.02) | Loss narrowed |
| EPS, basic (₹) | (0.85) | — | — | (1.30) | Loss narrowed |
| Net margin (%) | -3.3 | — | -5.7 |
Standalone
- Filed with BSE
- 15 Nov 2018, 13:57 IST
- Board meeting
- 13 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE